Capital International Investors
SAGE

Capital International Investors’s Sage Therapeutics SAGE Stock Holding History

Capital International Investors’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-69,010
Closed -$5.97M – 463
2020
Q4 		$5.97M Hold
69,010
– – ﹤0.01% 423
2020
Q3 		$4.22M Sell
69,010
-366,301
-84% -$18.6M ﹤0.01% 415
2020
Q2 		$18.1M Sell
435,311
-3,241,036
-88% -$118M 0.01% 358
2020
Q1 		$106M Sell
3,676,347
-137,729
-4% -$7.98M 0.04% 210
2019
Q4 		$275M Buy
3,814,076
+157,060
+4% +$19.3M 0.09% 165
2019
Q3 		$513M Buy
3,657,016
+516,724
+16% +$86.4M 0.2% 120
2019
Q2 		$575M Buy
+3,140,292
New +$536M 0.23% 109

Other funds holding SAGE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Capital International Investors's SAGE Position: Q1 2021 in Review

Capital International Investors sold out of Sage Therapeutics (SAGE) in Q1 2021, closing a stake of 69,010 shares — an estimated $5.97M sold.

Capital International Investors first reported a position in SAGE in Q2 2019 and held it in 7 quarters. The position peaked at $575M in Q2 2019. 263 funds tracked by Wall St. Rank hold SAGE as of Q1 2021.

  • Capital International Investors reported no remaining Sage Therapeutics position as of Q1 2021 after selling out during the quarter.
  • Capital International Investors sold 69,010 Sage Therapeutics shares in Q1 2021, an estimated $5.97M.
  • Capital International Investors first reported a position in Sage Therapeutics in Q2 2019 and held it in 7 quarters.
  • Capital International Investors's Sage Therapeutics position peaked at $575M in Q2 2019.
  • 263 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2021.

Based on Capital International Investors's 13F filing for Q1 2021, filed 14 May 2021.